5 unknown. 5 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Unknown 5 |
| Phase 1 | 2 | Unknown 2 |
Follow Precancerous Condition: new trials by email Literature Review of Precancerous Condition trials Research Report on Precancerous Condition
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tethered Capsule Endoscope in Screening Participants for Barrett Esophagus questionnaire administration, comparison of screening methods, diagnostic endoscopic procedure - Esophageal Cancer, Precancerous Condition | Phase 1 / Phase 2 | Unknown | US Department of Veterans Affairs | 50 | 2009-05-01 | 2014-01-10 |
| Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders anti-thymocyte globulin, busulfan, cyclophosphamide - Graft Versus Host Disease, Leukemia | Phase 2 | Unknown | Institut Paoli-Calmettes | 50 | 2008-01-01 | 2010-01-28 |
| SGN-00101 in Treating Patients With Cervical Intraepithelial Neoplasia HspE7 - Precancerous Condition | Phase 2 | Unknown | Dana-Farber/Brigham and Women's Cancer Center | 2003-05-01 | 2013-11-06 | |
| Beta Alethine in Treating Patients With Myeloma beta alethine - Multiple Myeloma and Plasma Cell Neoplasm, Precancerous Condition | Phase 1 / Phase 2 | Unknown | LifeTime Pharmaceuticals | 2000-08-01 | 2013-12-18 | |
| Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx autologous tumor cell vaccine - Precancerous Condition | Phase 2 | Unknown | University of Medicine and Dentistry of New Jersey | 1971-12-01 | 2011-07-26 |
Precancerous Conditions (5) · Multiple Myeloma (2) · Neoplasms, Plasma Cell (2) · Adenocarcinoma Of Esophagus (1) · Barrett Esophagus (1) · Burkitt Lymphoma (1) · Congenital Abnormalities (1) · Esophageal Neoplasms (1) · Graft vs Host Disease (1) · Hodgkin Disease (1) · Immunoblastic Lymphadenopathy (1) · Leukemia (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myeloid, Accelerated Phase (1) · Leukemia, Myeloid, Acute (1)
Neoplasms (5) · Blood Protein Disorders (2) · Cardiovascular Diseases (2) · DNA Virus Infections (2) · Disease Attributes (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemorrhagic Disorders (2) · Hemostatic Disorders (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Infections (2) · Lymphoproliferative Disorders (2) · Neoplasms by Histologic Type (2) · Paraproteinemias (2)
Antilymphocyte Serum (1) · Busulfan (1) · Cyclophosphamide (1) · Cyclosporine (1) · Endoscopy (1) · Endoscopy, Digestive System (1) · FANG vaccine (1) · Mycophenolic Acid (1) · alethine (1) · fludarabine phosphate (1)
Dana-Farber/Brigham and Women's Cancer Center (1) · Institut Paoli-Calmettes (1) · LifeTime Pharmaceuticals (1) · US Department of Veterans Affairs (1) · University of Medicine and Dentistry of New Jersey (1)
United States (4) · France (1)
Didier Blaise, MD (1) · James M. Oleske, MD (1) · Jason A. Dominitz, MD (1) · Kristin A. Keefe, MD (1) · Suzin Mayerson, PhD (1)